Genetic susceptibility to variant Creutzfeldt-Jakob disease

Lancet

Volumn 361, Issue 9356, 2003, Pages 447-448

  Partanen, Jukka ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; METHIONINE;

ALLELE; AMINO ACID SUBSTITUTION; CREUTZFELDT JAKOB DISEASE; GENE FREQUENCY; GENE FUNCTION; GENETIC CODE; GENETIC MARKER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HLA SYSTEM; HLA TYPING; HUMAN; LABORATORY DIAGNOSIS; NOTE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; REPRODUCIBILITY; STATISTICAL ANALYSIS; UNITED KINGDOM;

EID: 0037425750     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12456-7     Document Type: Note

References (5)

1. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet. 354:1999;317-323.
2. Jackson G.S., Beck J.A., Navarrete C., et al. HLA-DQ7 antigen and resistance to variant CJD. Nature. 414:2001;269-270.
3. Mabbott N.A., Bruce M.E. The immunobiology of TSE diseases. J Gen Virol. 82:2001;2307-2318.
4. Glynne P.A., Price N.M. HLA and infectious diseases. Lechler R., Warrens A. HLA in health and disease. 2000;299-326 Academic Press, London UK.
5. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.